2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor

Details 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor

1997-11-03

2000-12-26

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514249, 514253, 514254, 514256, 514261, 514262, 514269, 514274, 514307, 514309, 514312, 514314, 514333, 544264, 544265, 544276, 544277, 544315, 544316, 544319, 544320, 544333, 544353, 544354, 544356, 544364, 544384, 544398, 544403, 546141, 546144, 546148, 546152, 546153, 546157, 546158, 546164, 546165, 546166, 546167, 546178, 546179, 546180, 546256, 5462717, A61K 3144, A61K 3147, A61K 31505, A61K 31495, C07D41300, C07D21518, C07D21500, C07D21700

Patent

active

061660418

ABSTRACT:
Novel compounds which are effective PDE IV inhibitors are disclosed. The present invention is directed to compounds having the general formula I ##STR1## wherein: X is a halogen;

REFERENCES:
patent: Re31429 (1983-10-01), Tull et al.
patent: 2320654 (1943-06-01), Riester
patent: 2691654 (1954-10-01), Hitchings
patent: 2844577 (1958-07-01), Acker
patent: 2903455 (1959-09-01), Strong et al.
patent: 2956998 (1960-10-01), Baizer
patent: 2957875 (1960-10-01), Lyttle et al.
patent: 2966488 (1960-12-01), Shive et al.
patent: 3079378 (1963-02-01), Schroeder
patent: 3129225 (1964-04-01), Shapiro
patent: 3135753 (1964-06-01), Hitchings
patent: 3136771 (1964-06-01), Liechti et al.
patent: 3215696 (1965-11-01), Denayer
patent: 3225046 (1965-12-01), Zwahlen
patent: 3262929 (1966-07-01), Okubu et al.
patent: 3470164 (1969-09-01), Takamatsu
patent: 3491091 (1970-01-01), Berger
patent: 3491106 (1970-01-01), Freyermuth
patent: 3494919 (1970-02-01), Collins et al.
patent: 3516997 (1970-06-01), Takano et al.
patent: 3541100 (1970-11-01), Ramirez et al.
patent: 3551554 (1970-12-01), Herschler
patent: 3574218 (1971-04-01), Hideg et al.
patent: 3586670 (1971-06-01), Brenneisen
patent: 3590029 (1971-06-01), Koch et al.
patent: 3626018 (1971-12-01), Taylor
patent: 3636039 (1972-01-01), Gruenman et al.
patent: 3647812 (1972-03-01), Smith
patent: 3658799 (1972-04-01), Eardley et al.
patent: 3666769 (1972-05-01), Jones
patent: 3669979 (1972-06-01), Freyermuth
patent: 3674781 (1972-07-01), Schinzel et al.
patent: 3681328 (1972-08-01), Kurita et al.
patent: 3686238 (1972-08-01), Zaffaroni
patent: 3706834 (1972-12-01), Schellenbaum et al.
patent: 3923833 (1975-12-01), Gruenmann et al.
patent: 3962452 (1976-06-01), Evans et al.
patent: 4020165 (1977-04-01), Hubbard et al.
patent: 4025636 (1977-05-01), Dunwell et al.
patent: 4025637 (1977-05-01), Dunwell
patent: 4107306 (1978-08-01), Voorhees
patent: 4146721 (1979-03-01), Rainer
patent: 4167628 (1979-09-01), Kormany
patent: 4233303 (1980-11-01), Bergstrand et al.
patent: 4241063 (1980-12-01), Naito et al.
patent: 4241168 (1980-12-01), Arai et al.
patent: 4308278 (1981-12-01), Schneider et al.
patent: 4361699 (1982-11-01), Rasmusson et al.
patent: 4407802 (1983-10-01), Graham et al.
patent: 4416892 (1983-11-01), Dawson
patent: 4454138 (1984-06-01), Goring
patent: 4469698 (1984-09-01), Philippossian et al.
patent: 4495195 (1985-01-01), Beck et al.
patent: 4616020 (1986-10-01), Furrer et al.
patent: 4652654 (1987-03-01), Verga et al.
patent: 4684656 (1987-08-01), Atwal
patent: 4684728 (1987-08-01), Mohring et al.
patent: 4710503 (1987-12-01), Hofer
patent: 4732978 (1988-03-01), Kreft et al.
patent: 4755517 (1988-07-01), Bruns et al.
patent: 4757124 (1988-07-01), Koyanagi et al.
patent: 4769377 (1988-09-01), Snyder et al.
patent: 4770990 (1988-09-01), Nakamura et al.
patent: 4803216 (1989-02-01), Appleton et al.
patent: 4810719 (1989-03-01), Appleton et al.
patent: 4826868 (1989-05-01), Wachter et al.
patent: 4831152 (1989-05-01), Itoh et al.
patent: 4851321 (1989-07-01), Takagi et al.
patent: 4868183 (1989-09-01), Kanai et al.
patent: 4874869 (1989-10-01), Ueda et al.
patent: 4883801 (1989-11-01), Nathanson
patent: 4910211 (1990-03-01), Imamura et al.
patent: 4918074 (1990-04-01), Tsuda et al.
patent: 4925847 (1990-05-01), Hofer
patent: 4965169 (1990-10-01), Hirano et al.
patent: 4971972 (1990-11-01), Doll et al.
patent: 4981857 (1991-01-01), Daluge et al.
patent: 4994363 (1991-02-01), Koya et al.
patent: 5010081 (1991-04-01), Hofer
patent: 5047411 (1991-09-01), Takasugi et al.
patent: 5057517 (1991-10-01), Johnston et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5091431 (1992-02-01), Tulshian et al.
patent: 5098464 (1992-03-01), Barton et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5114835 (1992-05-01), Sakaoue
patent: 5116717 (1992-05-01), Matsushita et al.
patent: 5117830 (1992-06-01), McAfee et al.
patent: 5139921 (1992-08-01), Takagi et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5190942 (1993-03-01), Poss
patent: 5191084 (1993-03-01), Bagli et al.
patent: 5202243 (1993-04-01), Balani
patent: 5206255 (1993-04-01), Ubasawa et al.
patent: 5264589 (1993-11-01), Corey
patent: 5270206 (1993-12-01), Saccomano
patent: 5288896 (1994-02-01), Capiris et al.
patent: 5290782 (1994-03-01), Suzuki et al.
patent: 5322847 (1994-06-01), Marfat et al.
patent: 5342835 (1994-08-01), Pepin et al.
patent: 5424432 (1995-06-01), Fredenburgh et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5436258 (1995-07-01), Blake et al.
patent: 5449686 (1995-09-01), Christensen, IV
patent: 5451596 (1995-09-01), Ullrich
patent: 5496853 (1996-03-01), Shiota et al.
patent: 5602157 (1997-02-01), Christensen, IV
patent: 5602173 (1997-02-01), Christensen, IV
patent: 5631260 (1997-05-01), Belardinelli et al.
patent: 5665737 (1997-09-01), Cavalla et al.
Cariuk et a. Chem. Abstr vol. 128 entry 153640, 1998.
"The Synthesis of Some 6 Thioxanthines", K.R.H. Wooldrige and R. Slack, J. Chem. Soc. 1962, Annex IV;1863-1868.
Derwent Abstract of JP 58111034, published Jul. 1, 1983.
Ronald E. Weishaar, et al.., Subclasses of Cyclic GMP-Specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor, Dept. Of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co. Hypertension, vol. 15, No. 5, May 1990.
"Differential modulation of tissue function and therapeutic potential selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes", C. David Nicholson, R.A. John Chaliss and Mohammed Shahid, 1991, Elsevier Science Publishers Ltd. (UK), TIPS 12:19-27.
"Phosphodiesterase inhibiots: new opportunities for the treatment of asthma", Theodore J. Torphy, Bradley J. Undem, Thorax 1991; 46:512-523.
"Novel phosphodiesterase inhibitors for the therapy of asthma", Theodore J. Torphy, George P. Livi and Siegfried B. Christensen, DN&P 6(4), May 1993 pp. 203-214.
"Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme", W. Joseph Thompson, Wesley L. Terasaki, Paul M. Epstein, Samuel J. Strada, Advances in Cyclic Nucleotide Research, vol. 10, 1979, pp. 69-92.
"Identification characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle", Theodore J. Torphy, Bradley J. Undem, Lenora B. Cieslinski, Mark A. Luttmann, Martin L. Reeves and Douglas W.P. Hay, The Journal of Pharmacology and Experimental Therapeutics, 1993, vol. 265, No. 3, 1213-1223.
"The PDE IV family of calcium-independent phosphodiesterase enzymes", John A. Lowe III and John B. Cheng, Drugs of the Future, 1992, 17(9):799-807.
"Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?", Mark A. Giembycz, Biochemical Pharmacology, 1992, vol. 43, No. 10 pp. 2041-2051.
"Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes from cardiac muscle, arterial and airway smooth muscle", Paul J. Silver, Linda T. Hamel, Mark H. Perrone, Ross G. Bently, Cynthia R. Bushover and Dale B. Evans, European Journal of Pharmacology, 150 (1988) 85-94, Elsevier.
"The pharmacology and therapeutic use of theophylline", Miles Weinberger, M.D., The Journal of Allergy and Clinical Immunology, vol. 73, No. 5, Part 1, 525-544, 1984.
"Structure-Activity Relationships in a Series of 6-Thioxanthines with Bronchodilator and Coronary Dilator Properties", A.K. Armitrage, Janet Boswood and B.J. Large, Brit. J. Pharma. 1961, 17:196-207.
Chemical Abstracts, vol. 85, No. 1 (Jul. 5, 1976) 5692s (Enoki).
Chemical Abstracts, vol. 84, No. 25 (Jun. 21, 1976) 180299v (Enoki).
Chemical Abstracts, vol. 86, No. 7 (Feb. 14, 1977) 43746r (Aida).
Isomura et al., "Studies of the synthesis and anti-inflammatory activity of 2,6-Di-tert-butylphenols with a heterocyclic group at the 4-position.I", vol. 31, No. 9, pp. 3168-3178 (1983).
Chemical Abstracts 103: 37354, 1985 (Nagarajan).
Chemical Abstracts 116: 255335, 1992 (Bender).
Itaya, Tetrahedron Letters, vol. 23, No. 21 (1982), pp. 2203-2204.
Reitz, Journal of Organic Chemistry, vol.

Affiliated with

Also associated with

Rating

2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-995251